We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-16.43%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$791B
AUM Growth
-$200B
Cap. Flow
-$11.4B
Cap. Flow %
-1.44%
Top 10 Hldgs %
26.42%
Holding
3,063
New
88
Increased
1,490
Reduced
1,207
Closed
101

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$3.46B
2
UNH icon
UnitedHealth
UNH
+$2.79B
3
CRM icon
Salesforce
CRM
+$2.38B
4
SHW icon
Sherwin-Williams
SHW
+$1.41B
5
PM icon
Philip Morris
PM
+$1.34B

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 19.49%
3 Consumer Discretionary 13.07%
4 Financials 11.17%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNC icon
76
PNC Financial Services
PNC
$102B
$2.12B 0.27%
13,413,715
+2,373,814
+22% +$398M
KO icon
77
Coca-Cola
KO
$373B
$2.08B 0.26%
33,019,808
-13,791,742
-29% -$874M
TFX icon
78
Teleflex
TFX
$6.03B
$2.05B 0.26%
8,335,146
+1,407,946
+20% +$410M
TXT icon
79
Textron
TXT
$15.3B
$2.05B 0.26%
33,548,770
-538,229
-2% -$35.3M
KDP icon
80
Keurig Dr Pepper
KDP
$40.2B
$2.02B 0.26%
57,201,086
-20,148,678
-26% -$731M
BAC icon
81
Bank of America
BAC
$453B
$2.02B 0.25%
64,774,816
-33,352,250
-34% -$1.2B
LHX icon
82
L3Harris
LHX
$54.1B
$2.01B 0.25%
8,309,912
+875,587
+12% +$211M
UPS icon
83
United Parcel Service
UPS
$88.4B
$1.98B 0.25%
10,856,756
-5,748,704
-35% -$1.05B
A icon
84
Agilent Technologies
A
$41.9B
$1.98B 0.25%
16,652,764
+223,279
+1% +$27.5M
KLAC icon
85
KLA
KLAC
$272B
$1.98B 0.25%
61,981,270
+15,799,260
+34% +$531M
NEE icon
86
NextEra Energy
NEE
$179B
$1.96B 0.25%
25,317,552
-10,123,880
-29% -$771M
AEE icon
87
Ameren
AEE
$30.1B
$1.9B 0.24%
21,076,973
+394,677
+2% +$36.5M
WST icon
88
West Pharmaceutical
WST
$24.8B
$1.89B 0.24%
6,247,573
-133,485
-2% -$43.4M
SE icon
89
Sea Limited
SE
$78.5B
$1.88B 0.24%
28,188,004
-422,985
-1% -$36.1M
BALL icon
90
Ball Corp
BALL
$16.4B
$1.88B 0.24%
27,295,137
+4,022,652
+17% +$305M
SPGI icon
91
S&P Global
SPGI
$121B
$1.85B 0.23%
5,490,342
+2,065,830
+60% +$736M
PFE icon
92
Pfizer
PFE
$150B
$1.83B 0.23%
34,938,210
-404,839
-1% -$20.6M
GPN icon
93
Global Payments
GPN
$23.4B
$1.79B 0.23%
16,156,040
+923,414
+6% +$117M
XOM icon
94
ExxonMobil
XOM
$657B
$1.75B 0.22%
20,436,069
+2,016,377
+11% +$182M
ZTS icon
95
Zoetis
ZTS
$30.4B
$1.72B 0.22%
10,010,124
+504,073
+5% +$87.2M
PCTY icon
96
Paylocity
PCTY
$7.73B
$1.71B 0.22%
9,778,582
+1,003,092
+11% +$183M
EOG icon
97
EOG Resources
EOG
$75.1B
$1.7B 0.22%
15,425,915
+4,291,887
+39% +$533M
LULU icon
98
lululemon athletica
LULU
$13.7B
$1.69B 0.21%
6,197,234
-2,736,716
-31% -$877M
NXPI icon
99
NXP Semiconductors
NXPI
$58.9B
$1.68B 0.21%
11,353,534
+6,744,875
+146% +$1.17B
NKE icon
100
Nike
NKE
$60.1B
$1.68B 0.21%
16,434,980
-4,049,167
-20% -$479M

Similar funds

T. Rowe Price Associates's Q2 2022 Portfolio in Review

As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
  • T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
  • T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
  • T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
  • T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.